Get started
Author

Mercè Roget

Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis
2008 · Ferran Cereto, Xavier Herranz, et al. · European Journal of Gastroenterology & Hepatology · 45
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
2019 · Qian Chen, Celia Perales, et al. · Antiviral Research · 43
PDF
Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease
2017 · Sabela Lens, Inmaculada Fernández, et al. · The American Journal of Gastroenterology · 29
Results of a Study of Prolonging Treatment with Pegylated Interferon-α2A plus Ribavirin in HIV/HCV-Coinfected Patients with No Early Virological Response
2006 · Daniel Fuster, Ramon Planas, et al. · Antiviral Therapy · 24
PDF
Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy
2005 · Daniel Fuster, Jaime A Huertas, et al. · Antiviral Therapy · 23
PDF
Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients
2017 · Jordi Navarro, Montserrat Laguno, et al. · Journal of Antimicrobial Chemotherapy · 18
PDF
Evolving epidemiology of HCC in Spain
2025 · Margarita Sala, Sonia Pascual, et al. · JHEP Reports · 11
PDF
Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization
2018 · Jordi Sánchez-Delgado, Mercedes Vergara, et al. · European Journal of Gastroenterology & Hepatology · 11
Current trends in access to treatment for hepatitis B in immigrants vs non-immigrants
2020 · Mireia Miquel, Albert Pardo, et al. · Gastroenterology report · 10
PDF
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice – Vie-KinD study
2019 · María-Carlota Londoño, Mar Riveiro-Barciela, et al. · PLoS ONE · 10
PDF
Recompensation Following Alcohol-Related Hepatitis Is Associated With Increased Survival: Results From a Multicenter Study
2026 · Jordi Gratacós-Ginès, Pilar Ruz-Zafra, et al. · Clinical Gastroenterology and Hepatology · 4
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
2022 · Joan Martínez-Campreciós, Mar Riveiro-Barciela, et al. · Gastroenterología y Hepatología · 4
Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes
2026 · María Del Barrio, Margarita Sala, et al. · Liver International · 1
Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
2022 · Anna Soria, Mariona Calvo, et al. · Frontiers in Oncology · 1
PDF
TOP-149-YI Plasmatic expression of miR122-5p and miR21-5p predicts relapse of autoimmune hepatitis after treatment withdrawal
2024 · Pinelopi Arvaniti, Olga Millán, et al. · Journal of Hepatology
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
2023 · Joan Martínez-Campreciós, Mar Riveiro-Barciela, et al. · Gastroenterología y Hepatología (English Edition)
B cell reactivation in autoimmune hepatitis after immunosuppression withdrawal
2022 · Elena Perpinan, George Koutsoudakis, et al. · Journal of Hepatology
Works count: 18
Citation count: 252
H-index: 10
I10-index: 11
Year
Topic
Type